|
|
|
|
|
|
|
|
-
Salix, Progenics Announce FDA Advisory Committee To Review Relistor SNDA For Opioid-Induced Constipation
6/11/2013
|
|
|
-
Salix Pharmaceuticals Acquires Worldwide Rights To Olon’s Intellectual Property Relating To Amorphous Rifaximin
5/30/2013
|
-
Salix Pharma Reports Significant Results For Budesonide Foam In Active Mild To Moderate Ulcerative Proctitis
5/22/2013
|
|
|
-
Salix Pharmaceuticals Posts Q1 EPS Of $0.35 Vs. $0.15 Year Ago
5/9/2013
|